LORAZEPAM-D4
- CAS No.
- 84344-15-0
- Chemical Name:
- LORAZEPAM-D4
- Synonyms
- LORAZEPAM-D4;Lorazepam-d4 (CRM);Lorazepam-d4 solution;LORAZEPAM-D4,100/MLINACETONITRILE;Lorazepam-D4, 1mg/ml in Acetonitrile;Lorazepam-D4 1.0 mg/ml in Acetonitrile;Lorazepam-D4 0.1 mg/ml in Acetonitrile;LORAZEPAM (D4, 98%) 100 UG/ML IN ACETONITRILE;LORAZEPAM (D4, 98%) 1.0 MG/ML IN ACETONITRILE;2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(6-chlorophenyl-2,3,4,5-d4)-1,3-dihydro-3-hydroxy-
- CBNumber:
- CB0678490
- Molecular Formula:
- C15H10Cl2N2O2
- Molecular Weight:
- 321.16
- MDL Number:
- MFCD00673284
- MOL File:
- 84344-15-0.mol
- MSDS File:
- SDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS02,GHS07 |
|---|---|
| Signal word | Danger |
| Hazard statements | H225-H302+H312+H332-H319 |
| Precautionary statements | P210-P261-P302+P352+P312-P304+P340+P312-P337+P313-P403+P235-P280-P305+P351+P338 |
| Hazard Codes | F,Xn |
| Risk Statements | 11-20/21/22-36 |
| Safety Statements | 16-36/37 |
| RIDADR | UN 1648 3 / PGII |
| WGK Germany | 2 |
LORAZEPAM-D4 price More Price(6)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | L-911 | Lorazepam-d4 solution 1.0?mg/mL in acetonitrile, ampule of 1?mL, certified reference material, Cerilliant? | 84344-15-0 | 1mL | $195 | 2026-04-30 | Buy |
| Sigma-Aldrich | L-902 | Lorazepam-d4 solution 100?μg/mL in acetonitrile, ampule of 1?mL, certified reference material, Cerilliant? | 84344-15-0 | 1mL | $49.1 | 2026-04-30 | Buy |
| Cayman Chemical | 40658 | Lorazepam-d4 ≥99%deuteratedforms(d1-d4) | 84344-15-0 | 1mg | $146 | 2026-04-30 | Buy |
| Cayman Chemical | 18728 | Lorazepam-d4 (CRM) | 84344-15-0 | 100μg | $49 | 2026-04-30 | Buy |
| Usbiological | 453898 | Lorazepam-d4 | 84344-15-0 | 500ug | $602 | 2026-06-03 | Buy |
LORAZEPAM-D4 Chemical Properties,Uses,Production
Uses
Lorazepam-d4 is labelled Lorazepam (L469850) which is a high-potency, intermediate-duration, 3-hydroxy benzodiazepine drug, It is often used to treat anxiety disorders.
References
[1] L G MILLER. Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function.[J]. Journal of Pharmacology and Experimental Therapeutics, 1988, 246 1: 170-176.
[2] DAVID BALDWIN. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis.[J]. BMJ : British Medical Journal, 2011: d1199. DOI: 10.1136/bmj.d1199
[3] BJOERN MOOSMANN Volker A Philippe Bisel. Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics[J]. Drug Testing and Analysis, 2014, 6 7-8: 757-763. DOI: 10.1002/dta.1628
